Free Trial
→ Iran War Update: Trump’s Hand-Written Letter Reveals What Comes Next (From Paradigm Press) (Ad)tc pixel Free ALDX Stock Alerts

Aldeyra Therapeutics (ALDX) Institutional Ownership

Aldeyra Therapeutics logo
$1.68 -0.03 (-1.47%)
As of 02:13 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Aldeyra Therapeutics (NASDAQ:ALDX)

Current
Institutional Ownership
Percentage
59.71%
Number of
Institutional Buyers
(last 12 months)
76
Total
Institutional Inflows
(last 12 months)
$39.27M
Number of
Institutional Sellers
(last 12 months)
31
Total
Institutional Outflows
(last 12 months)
$39.73M
Get ALDX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Aldeyra Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ALDX Institutional Buying and Selling by Quarter

Aldeyra Therapeutics Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/7/2026 Dimensional Fund Advisors LP624,170$1.06M0.0%+1.9%1.035%
5/5/2026 Bank of New York Mellon Corp136,746$231K0.0%+18.1%0.227%
5/4/2026 Chicago Partners Investment Group LLC19,523$33K0.0%N/A0.032%
5/2/2026 International Assets Investment Management LLC37,360$63K0.0%-21.3%0.062%
4/28/2026 Abel Hall LLC15,142$26K0.0%N/A0.025%
4/17/2026 Krilogy Financial LLC14,459$26K0.0%N/A0.024%
2/19/2026 Invesco Ltd.163,087$845K0.0%+22.0%0.271%
2/18/2026Mercer Global Advisors Inc. ADV10,571$55K0.0%-26.5%0.018%
2/18/2026XTX Topco Ltd42,227$219K0.0%+22.5%0.070%
2/18/2026Wellington Management Group LLP178,851$926K0.0%-5.8%0.297%
2/18/2026Perceptive Advisors LLC4,185,632$21.68M0.4%-19.9%6.958%
2/18/2026Millennium Management LLC44,059$228K0.0%-75.4%0.073%
2/18/2026Caption Management LLC35,000$181K0.0%N/A0.058%
2/18/2026683 Capital Management LLC1,530,000$7.93M0.3%+86.6%2.543%
2/18/2026 ACT Capital Management LLC41,000$212K0.2%N/A0.068%
2/17/2026AQR Capital Management LLC1,226,922$6.36M0.0%-18.5%2.039%
2/17/2026Jump Financial LLC24,480$127K0.0%N/A0.041%
2/17/2026 Russell Investments Group Ltd.114,126$591K0.0%+2.7%0.190%
2/17/2026State of Wisconsin Investment Board81,366$421K0.0%+33.6%0.135%
2/17/2026ExodusPoint Capital Management LP92,390$479K0.0%+518.0%0.154%
2/17/2026Graham Capital Management L.P.76,365$396K0.0%+66.3%0.127%
2/16/2026Mariner LLC22,876$118K0.0%-23.4%0.038%
2/16/2026Kennedy Capital Management LLC1,255,838$6.51M0.1%+12.9%2.087%
2/16/2026Barclays PLC84,471$438K0.0%+10.2%0.140%
2/13/2026The Manufacturers Life Insurance Company 17,021$88K0.0%-11.2%0.028%
2/13/2026 Walleye Capital LLC18,595$96K0.0%N/A0.031%
2/13/2026Jacobs Levy Equity Management Inc.968,751$5.02M0.0%+2.2%1.610%
2/13/2026Charles Schwab Investment Management Inc.152,787$791K0.0%+1.5%0.254%
2/13/2026 Police & Firemen s Retirement System of New Jersey10,721$56K0.0%-39.2%0.018%
2/13/2026State Street Corp1,098,600$5.69M0.0%-0.4%1.826%
2/13/2026Ieq Capital LLC144,199$747K0.0%-9.4%0.240%
2/12/2026Federation des caisses Desjardins du Quebec12,187$63K0.0%+25.8%0.020%
2/12/2026MetLife Investment Management LLC29,531$153K0.0%+60.5%0.049%
2/12/2026Renaissance Technologies LLC350,000$1.81M0.0%+77.4%0.582%
2/12/2026 Dimensional Fund Advisors LP612,258$3.17M0.0%-5.6%1.018%
2/12/2026 AlphaCentric Advisors LLC34,912$181K0.2%N/A0.058%
2/12/2026 Nuveen LLC108,220$561K0.0%-25.2%0.180%
2/11/2026 Deutsche Bank AG317,335$1.64M0.0%+0.8%0.527%
2/11/2026Focus Partners Advisor Solutions LLC10,535$55K0.0%-27.9%0.018%
2/11/2026 Fox Run Management L.L.C.20,983$109K0.0%N/A0.035%
NNVC FDA = New Momentum Wave! (Ad)

NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for its antiviral NV-387, targeting measles at a time when no approved antiviral treatments exist and cases are resurging globally. Beyond measles, NV-387 is designed as a broad-spectrum platform targeting RSV, influenza, coronaviruses, Mpox, and more - giving NNVC exposure to multiple large markets as Phase II trials advance.tc pixel

See why this FDA milestone could be a catalyst for NNVC
2/11/2026Cerity Partners LLC51,049$264K0.0%-15.4%0.085%
2/10/2026 1492 Capital Management LLC223,317$1.16M0.4%N/A0.371%
2/10/2026Goldman Sachs Group Inc.305,706$1.58M0.0%+67.1%0.508%
2/10/2026AXQ Capital LP26,810$139K0.0%N/A0.045%
2/10/2026 Intech Investment Management LLC33,328$173K0.0%+57.1%0.055%
2/9/2026Geode Capital Management LLC1,170,537$6.07M0.0%-0.5%1.946%
2/6/2026Global Retirement Partners LLC10,000$52K0.0%N/A0.017%
2/2/2026 Strs Ohio68,200$353K0.0%-20.4%0.113%
1/28/2026Joseph P. Lucia & Associates LLC26,732$138K0.0%-15.4%0.044%
1/26/2026CWM LLC43,305$224K0.0%-25.8%0.072%
1/26/2026 PFG Investments LLC15,500$80K0.0%-76.5%0.026%
1/23/2026 U.S. Capital Wealth Advisors LLC14,805$77K0.0%N/A0.025%
1/21/2026 Capital Advisors Wealth Management LLC15,800$82K0.0%+46.3%0.026%
1/9/2026 SG Americas Securities LLC12,000$62K0.0%N/A0.020%
1/9/2026 Inspirion Wealth Advisors LLC10,000$52K0.0%N/A0.017%
11/24/2025CIBC Private Wealth Group LLC10,505$55K0.0%N/A0.017%
11/21/2025 CIBC Bancorp USA Inc.57,242$299K0.0%N/A0.095%
11/17/2025Jacobs Levy Equity Management Inc.947,551$4.95M0.0%+49.4%1.575%
11/17/2025Public Employees Retirement System of Ohio13,388$70K0.0%+106.0%0.022%
11/17/2025Mercer Global Advisors Inc. ADV14,385$75K0.0%N/A0.024%
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.25,498$133K0.0%-10.8%0.042%
11/17/2025Bank of America Corp DE390,078$2.04M0.0%+590.5%0.648%
11/17/2025Ameriprise Financial Inc.35,409$185K0.0%+34.8%0.059%
11/14/2025 Creative Planning34,848$182K0.0%+189.3%0.058%
11/14/2025 Brooklyn Investment Group12,691$66K0.0%+24,784.3%0.021%
11/14/2025Two Sigma Investments LP273,054$1.43M0.0%+389.9%0.454%
11/13/2025Kennedy Capital Management LLC1,112,213$5.81M0.1%+61.9%1.849%
11/13/2025Sei Investments Co.39,359$205K0.0%N/A0.065%
11/13/2025 UBS Group AG200,739$1.05M0.0%+87.2%0.334%
11/13/2025 BNP Paribas Financial Markets10,610$55K0.0%+36.9%0.018%
11/13/2025 Russell Investments Group Ltd.111,102$580K0.0%+321.7%0.185%
11/12/2025 Dimensional Fund Advisors LP648,371$3.38M0.0%-9.8%1.078%
11/12/2025 Intech Investment Management LLC21,211$111K0.0%-29.3%0.035%
11/7/2025 GSA Capital Partners LLP122,664$640K0.1%+67.4%0.205%
11/7/2025Vanguard Group Inc.3,591,869$18.75M0.0%+2.6%5.997%
10/31/2025 PFG Investments LLC66,000$345K0.0%-74.3%0.110%
10/31/2025 Y Intercept Hong Kong Ltd138,091$721K0.0%N/A0.231%
10/30/2025 Strs Ohio85,700$447K0.0%+4.1%0.143%
10/29/2025 Inscription Capital LLC12,633$66K0.0%N/A0.021%
10/29/2025 Wealth Enhancement Advisory Services LLC32,842$184K0.0%+20.4%0.055%
10/15/2025CWM LLC58,379$305K0.0%+39.8%0.097%
10/14/2025 Brighton Jones LLC19,945$104K0.0%+11.4%0.033%
10/9/2025 Voya Investment Management LLC10,066$53K0.0%-33.9%0.017%
8/15/2025Captrust Financial Advisors51,492$197K0.0%+9.1%0.086%
8/15/2025Perceptive Advisors LLC4,051,631$15.52M1.4%-56.3%6.764%
8/15/2025 BNP Paribas Financial Markets7,751$30K0.0%-71.4%0.013%
8/15/2025Bank of America Corp DE56,491$216K0.0%-86.2%0.094%
8/15/2025683 Capital Management LLC1,080,000$4.14M0.3%+126.9%1.803%
8/15/2025Ameriprise Financial Inc.26,263$101K0.0%N/A0.044%
8/15/2025AQR Capital Management LLC1,473,812$5.65M0.0%+275.4%2.460%
NNVC FDA = New Momentum Wave! (Ad)

NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for its antiviral NV-387, targeting measles at a time when no approved antiviral treatments exist and cases are resurging globally. Beyond measles, NV-387 is designed as a broad-spectrum platform targeting RSV, influenza, coronaviruses, Mpox, and more - giving NNVC exposure to multiple large markets as Phase II trials advance.tc pixel

See why this FDA milestone could be a catalyst for NNVC
8/14/2025Caption Management LLC12,664$49K0.0%-110.6%0.021%
8/14/2025The Manufacturers Life Insurance Company 20,074$77K0.0%+10.9%0.034%
8/14/2025Ardsley Advisory Partners LP2,050,000$7.85M1.0%-4.7%3.422%
8/14/2025Cerity Partners LLC36,577$140K0.0%N/A0.061%
8/13/2025Kennedy Capital Management LLC686,968$2.63M0.1%-44.3%1.147%
8/13/2025 Invesco Ltd.122,566$469K0.0%-75.5%0.205%
8/13/2025Panagora Asset Management Inc.72,059$276K0.0%+42.8%0.120%
8/13/2025 Kennondale Capital Management LLC56,729$217K0.2%-62.5%0.095%
8/12/2025 Rhumbline Advisers77,494$297K0.0%+2.7%0.129%
8/8/2025 Intech Investment Management LLC29,983$115K0.0%+27.6%0.050%


ALDX Institutional Ownership - Frequently Asked Questions

During the previous two years, 119 institutional investors and hedge funds held shares of Aldeyra Therapeutics. The most heavily invested institutionals were Perceptive Advisors LLC ($21.68M), Vanguard Group Inc. ($18.75M), 683 Capital Management LLC ($7.93M), Ardsley Advisory Partners LP ($7.85M), Kennedy Capital Management LLC ($6.51M), AQR Capital Management LLC ($6.36M), and Geode Capital Management LLC ($6.07M).Learn more on Aldeyra Therapeutics' institutional investors.

59.71% of Aldeyra Therapeutics' stock is owned by institutional investors. Learn more on ALDX's institutional investor holdings.

Of the 104 institutional investors that purchased Aldeyra Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: 683 Capital Management LLC ($1.79M), Raymond James Financial Inc. ($1.45M), AQR Capital Management LLC ($1.40M), Jacobs Levy Equity Management Inc. ($847.36K), Kingdon Capital Management L.L.C. ($779K), Perceptive Advisors LLC ($682.27K), and Kennedy Capital Management LLC ($610.88K).

Institutional investors have bought a total of 8,080,670 shares in the last 24 months. This purchase volume represents approximately $39.27M in transactions.

Of the 31 institutional investors that sold Aldeyra Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Perceptive Advisors LLC ($6.26M), Kennedy Capital Management LLC ($546.45K), ADAR1 Capital Management LLC ($436.38K), Invesco Ltd. ($378.57K), Bank of America Corp DE ($352.05K), AQR Capital Management LLC ($278.44K), and PFG Investments LLC ($241.80K).

Institutional investors have sold a total of 9,351,712 shares in the last 24 months. This volume of shares sold represents approximately $39.73M in transactions.


Related Companies

This page (NASDAQ:ALDX) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
NNVC FDA = New Momentum Wave!
NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for its antiviral NV-387, targeting measl...
Equiscreen | Sponsoredtc pixel
Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...
The Tomorrow Investor | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel